RE: A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer

from Cancer via ola Kala on Inoreader http://ift.tt/1W1YoRY
via IFTTT